356 related articles for article (PubMed ID: 34580009)
21. In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Donati M; Di Francesco A; D'Antuono A; Delucca F; Shurdhi A; Moroni A; Baldelli R; Cevenini R
Antimicrob Agents Chemother; 2010 Dec; 54(12):5379-80. PubMed ID: 20855744
[TBL] [Abstract][Full Text] [Related]
22. Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum.
Maeda S; Tamaki M; Kubota Y; Nguyen PB; Yasuda M; Deguchi T
Int J Urol; 2007 May; 14(5):422-5. PubMed ID: 17511725
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis and/or epididymitis.
Deguchi T; Ito S; Hatazaki K; Horie K; Yasuda M; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Hanaoka N; Shimuta K; Ohnishi M; Muratani T; Nakano M
J Infect Chemother; 2017 Nov; 23(11):804-807. PubMed ID: 28619239
[TBL] [Abstract][Full Text] [Related]
24. [Which is the best empirical treatment in patients with urethritis?].
Orellana MA; Gómez-Lus ML
Rev Esp Quimioter; 2011 Sep; 24(3):136-42. PubMed ID: 21947096
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
Johannisson G; Sernryd A; Lycke E
Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
[TBL] [Abstract][Full Text] [Related]
26. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
[TBL] [Abstract][Full Text] [Related]
27. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS
PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482
[TBL] [Abstract][Full Text] [Related]
28. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.
Bowie WR; Lee CK; Alexander ER
J Infect Dis; 1978 Nov; 138(5):655-9. PubMed ID: 712119
[TBL] [Abstract][Full Text] [Related]
29. Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.
Khaki P; Bhalla P; Sharma A; Kumar V
Indian J Med Microbiol; 2007 Oct; 25(4):354-7. PubMed ID: 18087084
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of azithromycin against Mycoplasma genitalium and its efficacy in the treatment of male Mycoplasma genitalium-positive nongonococcal urethritis.
Hagiwara N; Yasuda M; Maeda S; Deguchi T
J Infect Chemother; 2011 Dec; 17(6):821-4. PubMed ID: 21710162
[TBL] [Abstract][Full Text] [Related]
31. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
[TBL] [Abstract][Full Text] [Related]
32. Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
Foschi C; Salvo M; Cevenini R; Marangoni A
J Antimicrob Chemother; 2018 Feb; 73(2):409-413. PubMed ID: 29077843
[TBL] [Abstract][Full Text] [Related]
33. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
[TBL] [Abstract][Full Text] [Related]
34. Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility.
Watanabe A; Yanagihara K; Matsumoto T; Kohno S; Aoki N; Oguri T; Sato J; Muratani T; Yagisawa M; Ogasawara K; Koashi N; Kozuki T; Komoto A; Takahashi Y; Tsuji T; Terada M; Nakanishi K; Hattori R; Hirako Y; Maruo A; Minamitani S; Morita K; Wakamura T; Sunakawa K; Hanaki H; Ohsaki Y; Honda Y; Sasaoka S; Takeda H; Ikeda H; Sugai A; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Kobayashi N; Takasaki J; Konosaki H; Aoki Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Kobayashi Y; Katono Y; Kawana A; Saionji K; Miyazawa N; Sato Y; Watanuki Y; Kudo M; Ehara S; Tsukada H; Imai Y; Watabe N; Aso S; Honma Y; Mikamo H; Yamagishi Y; Takesue Y; Wada Y; Nakamura T; Mitsuno N; Mikasa K; Kasahara K; Uno K; Sano R; Miyashita N; Kurokawa Y; Takaya M; Kuwabara M; Watanabe Y; Doi M; Shimizu S; Negayama K; Kadota J; Hiramatsu K; Morinaga Y; Honda J; Fujita M; Iwata S; Iwamoto A; Ezaki T; Onodera S; Kusachi S; Tateda K; Tanaka M; Totsuka K; Niki Y; Matsumoto T
J Infect Chemother; 2012 Oct; 18(5):609-20. PubMed ID: 22766652
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.
Kohlhoff SA; Huband MD; Hammerschlag MR
Antimicrob Agents Chemother; 2014 Dec; 58(12):7595-6. PubMed ID: 25288086
[TBL] [Abstract][Full Text] [Related]
36. Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2017: General overview of pathogenic antimicrobial susceptibility.
Ishiwada N; Fujimaki K; Matsumoto T; Kiyota H; Tateda K; Sato J; Hanaki H; Takayanagi R; Yamaguchi Y; Hoshino T; Kuroki H; Iwata S; Tajima T; Horikoshi Y; Shiro H; Bamba M; Kawamura N; Ouchi K; Matsubara K; Okada T; Furuno K; Tsumura N
J Infect Chemother; 2021 Feb; 27(2):139-150. PubMed ID: 33277177
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial Sensitivity Profile of Chlamydia trachomatis isolates from Croatia in McCoy Cell Culture System and Comparison with the Literature.
Mestrović T; Ljubin-Sternak S; Sviben M; Bedenić B; Vranes J; Markotić A; Skerk V
Clin Lab; 2016; 62(3):357-64. PubMed ID: 27156324
[TBL] [Abstract][Full Text] [Related]
38. Comparison of E-test with agar dilution methods in testing susceptibility of N. gonorrhoeae to azithromycin.
Yasin RM; Suan KA; Meng CY
Sex Transm Dis; 1997 May; 24(5):257-60. PubMed ID: 9153733
[TBL] [Abstract][Full Text] [Related]
39. The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
Kobayashi K; Yamamoto S; Takahashi S; Ishikawa K; Yasuda M; Wada K; Hamasuna R; Hayami H; Minamitani S; Matsumoto T; Kiyota H; Tateda K; Sato J; Hanaki H; Masumori N; Hiyama Y; Yamada H; Egawa S; Kimura T; Nishiyama H; Miyazaki J; Matsumoto K; Homma Y; Kamei J; Fujimoto K; Torimoto K; Tanaka K; Togo Y; Uehara S; Matsubara A; Shoji K; Goto H; Komeda H; Ito T; Mori K; Mita K; Kato M; Fujimoto Y; Masue T; Inatomi H; Takahashi Y; Ishihara S; Nishimura K; Mitsumori K; Ito N; Kanamaru S; Yamada D; Hiroshi M; Yamashita M; Tsugawa M; Takenaka T; Takahashi K; Oka Y; Yasufuku T; Watanabe S; Chihara Y; Okumura K; Kawanishi H; Matsukawa M; Shigeta M; Koda S
J Infect Chemother; 2020 May; 26(5):418-428. PubMed ID: 32081647
[TBL] [Abstract][Full Text] [Related]
40. Is previous azithromycin treatment associated with azithromycin resistance in
Clifton S; Town K; Furegato M; Cole M; Mohammed H; Woodhall SC; Kevin Dunbar J; Fifer H; Hughes G
Sex Transm Infect; 2018 Sep; 94(6):421-426. PubMed ID: 29511067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
